*ST Jingfeng plans to rename to "Shiyao Group Jingfeng Pharmaceutical" with registered capital increased to 1.76 billion yuan

On the evening of March 17, Hunan Jingfeng Pharmaceutical Co., Ltd. (stock abbreviation: *ST Jingfeng, stock code: 000908) announced that the company plans to change its name to “CSPC Jingfeng Pharmaceutical Co., Ltd.” At the same time, its registered capital will double to 1.7595 billion yuan due to capital reserve conversion. The company’s stock abbreviation and code will remain unchanged.

The announcement states that the eighth board of directors held its 46th meeting via teleconference on March 17, approving the proposal to change the company name, registered capital, and amend the Articles of Incorporation. This matter still requires approval from the shareholders’ meeting.

Details of the Name Change

The company states that this name change complies with the relevant laws and regulations such as the Company Law and Securities Law, as well as the company’s Articles of Incorporation. It aligns with the company’s future development strategy and current operational needs. The change will not adversely affect the company’s production and operations, nor will it harm the interests of the company or shareholders.

Registered Capital Doubles to 1.76 Billion Yuan

According to the announcement, the company has previously implemented a capital reserve conversion plan: based on the current total share capital of 879,774,351 shares, it will increase by a ratio of 10 shares to 10 shares, totaling an increase of 879,774,351 shares. After the increase, the total share capital will reach 1,759,548,702 shares, which will be listed on March 11, 2026.

The registered capital will accordingly change from 879.77 million yuan to 1.7559 billion yuan.

Amendments to the Articles of Incorporation

In conjunction with the company’s restructuring plan and the name change, the relevant clauses of the Articles of Incorporation have been revised accordingly:

The company emphasizes that aside from the above amendments, other provisions of the Articles of Incorporation remain unchanged.

Progress and Impact of the Matters

The announcement specifically notes that the company’s stock abbreviation and code will remain unchanged. The above matters are still subject to approval by the shareholders’ meeting, and the company will seek authorization from the shareholders’ meeting (or its authorized persons) to handle various registration and filing procedures related to this change.

After the name change, the legal entity remains the same; existing contracts and agreements signed before the change remain valid. The company’s pre-change creditor and debtor relationships will be inherited by the renamed company. Any rules or regulations referencing the company name will be updated accordingly, without affecting their legal validity.

The company also reminds investors that the registration and filing procedures with the market supervision authorities are still pending, and there is some uncertainty. The company will disclose updates in a timely manner based on the progress and urges investors to be cautious of investment risks.

Click here to view the full announcement>>

Disclaimer: The market involves risks; investment should be cautious. This article is automatically generated by an AI model based on third-party databases and does not represent Sina Finance’s views. All information herein is for reference only and does not constitute personal investment advice. Please refer to the actual announcement for accuracy. For questions, contact biz@staff.sina.com.cn.